[1] | Roglic, G., Unwin, N., Bennett, P.H., Mathers C., Tuomilehto J, Nag, S., Connolly, V., and King, H., 2005, The burden of mortality attributable to diabetes: realistic estimates for the year 2000., Diabetes Care, 28(9), 2130-2135. |
[2] | Botnariu, G., and Bulgaru-Iliescu, D., 2010, Determinant Factors of Cardiovascular Mortality in Type 2 Diabetic Patients: literature review., Rom. J. Leg. Med., 18(4), 309 - 314. |
[3] | Saquib, N., Saquib, J., Ahmed, T., Khanam, M.A., and Cullen, M.R., 2012, Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010., BMC Public Health, 12, 434. |
[4] | IDF, 2013, International Diabetes Federation, Diabetes Atlas, 6th ed., Brussels, Belgium. |
[5] | Zimmet, P., Alberti, K. G and Shaw, J.. 2001, Global and societal implications of the diabetes epidemic., Nature, 414 (6865), 782–787. |
[6] | NIDDKD and AHA, 1999, Diabetes mellitus: a major risk factor for cardiovascular disease. A joint editorial statement by the American Diabetes Association; The National Heart, Lung, and Blood Institute; The Juvenile Diabetes Foundation International; The National Institute of Diabetes and Digestive and Kidney Diseases; and The American Heart Association. Circulation, 1999., 100 (10), 1132-1133. |
[7] | Brownrigg, J. R., Davey, J., Holt, P. J., Davis, W.A., Thompson, M.M., Ray, K.K., and Hinchliffe, R.J., 2012, The association of ulceration of the foot with cardiovascular and all-cause mortality in patients with diabetes: a meta-analysis., Diabetologia, 55 (11), 2906–2912. |
[8] | Olefsky, J., Farquhar, J. W., and Reaven, G., 1973. Relationship between fasting plasma insulin level and resistance to insulin-mediated glucose uptake in normal and diabetic subjects., Diabetes, 22(7), 507–513. |
[9] | Ramachandran, A., Snehalatha, C., Samith Shetty, A., and Nanditha, A., 2013, Primary prevention of Type 2 diabetes in South Asians challenges and the way forward., Diabet Med, 30 (1), 26-34. |
[10] | Ramachandran, A., Snehalatha, C., and Ma, R. C., 2014, Diabetes Atlas Diabetes in South-East Asia: An update., Diabetes Res Clin Pract, 103 (2), 231-237. |
[11] | Khanam, M. A., Qiu, C., Lindeboom, W., Streatfield, P.K., Kabir, Z.N., and Wahlin, A., 2011, The metabolic syndrome: Prevalence, associated factors, and impact on survival among older persons in rural Bangladesh., PLoS One, 6 (6), e20259. |
[12] | Ludvik, B., Nolan, J.J., Baloga, J., Sacks, D., and Olefsky, J., 1995, Effect of obesity on insulin resistance in normal subjects and patients with NIDDM., Diabetes, 44(9), 1121–1125. |
[13] | Mathieu, P., Lemieux, I., and Despres, J. P., 2010, Obesity, Inflammation, and Cardiovascular Risk., Clin Pharmacol Ther, 87 (4), 407-416. |
[14] | Swinburn, B. A., Sacks, G. and Hall, K. D., 2011, The global obesity pandemic: shaped by global drivers and local environments., Lancet, 378 (9793), 804–814. |
[15] | NIPORT and ICF, 2013, National Institute of Population Research and Training (NIPORT), Mitra and Associates, and ICF International. Bangladesh Demographic and Health Survey 2011. Dhaka, Bangladesh and Calverton, Maryland, USA. |
[16] | Hussain, A., Rahim, M. A., Azad Khan, A. K., Ali, S.M., and Vaaler, S., 2005, Type 2 diabetes in rural and urban population: diverse prevalence and associated risk factors in Bangladesh., Diabet. Med, 22(7), 931-936. |
[17] | Hussain, A., Vaaler, S., Sayeed, M. A., Mahtab, H., Keramat Ali, S. M., and Azad Khan, A. K., 2007, Type 2 diabetes and impaired fasting blood glucose in rural Bangladesh: a population based study., Eur. J. Public Health, 17 (3), 291–296. |
[18] | Bhowmik, B., Afsana, F., Diep, L.M., Munir, S.B., Wright, E., Mahmood, S., Azad Khan, A. K., and Hussain, A., 2013, Increasing Prevalence of Type 2 Diabetes in a Rural Bangladeshi Population: A Population Based Study for 10 Years., Diabetes Metab. J., 37(1), 46–53. |
[19] | Sayeed, M. A., Ali, L., Hussain, M. Z., Rumi, M. A., Banu, A., and Azad Khan, A. K., 1997, Effect of socio-economic risk factors on the difference in prevalence of diabetes between rural and urban populations in Bangladesh., Diabetes Care, 20 (4), 551-555. |
[20] | WHO, 2012, World Health Organization. Europe Obesity – Facts and Figures. Available at: https://0x9.me/Uz9Wt (accessed 2 Nov 2012). |
[21] | Bhowmik, B., Siddiquee, T., Mujumder, A., Rajib, M.M.R., Das, C.K., Khan, M.I., Khan, A.K.A., and Hussain, A., 2016, Identifying Insulin Resistance by Fasting Blood Samples in Bangladeshi population with Normal Blood Glucose., Journal of Diabetology, 3, 4. |
[22] | Wallace, T. M., Levy, J. C., Matthews, D. R., 2004, Use and abuse of HOMA modeling., Diabetes Care, 27(6), 1487– 1495. |
[23] | Campbell, P. T., Newton, C. C., Patel, A. V., Jacobs, E.J., and Gapstur, S.M., 2012, Diabetes and cause-specific mortality in a prospective cohort of one million U.S. adults., Diabetes Care, 35 (9), 1835–1844. |
[24] | American Heart Association, 2014, Cardiovascular Disease & Diabetes. Accessed Aug 4, 2014. Available online: https://0x9.me/PgSse. |
[25] | Goel, K., Misra, A., Vikram, N. K., Poddar, P., and Gupta, N., 2010, Subcutaneous abdominal adipose tissue is associated with the metabolic syndrome in Asian Indians independent of intra-abdominal and total body fat., Heart, 96 (8), 579–583. |
[26] | WHO, 2011, World Health Organization. Non-communicable disease risk factor survey, Bangladesh 2010. |
[27] | Australian Institute of Health and Welfare and National Heart Foundation of Australia, 2004, The relationship between overweight, obesity and cardiovascular disease, Cardiovascular Disease Series no. 23. Canberra: Australian Institute of Health and Welfare. |
[28] | Karar, Z. A., Alam, N. and Streatfield, P. K.. 2009, Epidemiological transition in rural Bangladesh, 1986–2006., Global Health Action. 2, 10.3402/gha.v2i0.1904. |
[29] | Reaven, G. M., 1995, Pathophysiology of insulin resistance in human disease., Physiol Rev, 75(3), 473–486. |
[30] | WHO/IDF, 2006, Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia - Report of a WHO/IDF consultation. |
[31] | Bagdade, J. D., Bierman, E. L., and Porte, D Jr., 1967, The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects., J. Clin. Invest., 46(10), 1549-1557. |
[32] | Pratley, R. E., Weyer, C., and Bogardus, C., 2000, Metabolic abnormalities in the development of noninsulin-dependent diabetes mellitus. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes mellitus, ed 2. Philadelphia Lippincot-Raven Publishers, 548–557. |
[33] | Ginsberg, H. N., 2000, Insulin resistance and cardiovascular disease., J. Clin. Invest., 106 (4), 453-458. |
[34] | Pechere-Bertschi, A., Greminger, P., Hess, L., Philippe, J., and Ferrari, P., 2005, Swiss Hypertension and Risk Factor Program (SHARP): Cardiovascular risk factors management in patients with type 2 diabetes in Switzerland., Blood Pressure, 14 (6), 337-344. |
[35] | NHBPEP, 2004, National High Blood Pressure Education Program. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health; National Heart, Lung, and Blood Institute., NIH Publication No. 04-5230, pp. 1-86. |
[36] | Mathieu, P., Pibarot, P., Larose, E., Poirier, P., Marette, A., and Despres, J.P., 2008, Visceral obesity and the heart., Int. J. Biochem Cell Biol., 40 (5), 821–836. |
[37] | Cushman, W. C., Evans, G. W., Byington, R. P., Goff, D.C., et al. (2010). Effects of intensive blood-pressure control in type 2 diabetes mellitus., N. Engl. J. Med., 362 (17), 1575-1585. |
[38] | AACC, 2015, American Association for Clinical Chemistry. "Cholesterol. Lab Tests Online." Accessed on Jan 15, 2015. https://labtestsonline.org/understanding/analytes/cholesterol. |
[39] | NCEP, 2001, National Cholesterol Education Program. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health; National Heart, Lung, and Blood Institute., NIH Publication No. 01-3670, pp. 1-27. |
[40] | Cummings, M. H., Watts, G. F., Umpleby, A. M., Hennessy, T. R., Naoumova, R., Slavin, B. M., Thompson, G. R., and Sönksen, P. H., 1995, Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM., Diabetologia, 38(8), 959-967. |
[41] | Malmstrom, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., and Taskinen, M. R., 1997. Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM., Diabetologia, 40 (4), 454-462. |
[42] | Carmena, R., Duriez, P., and Fruchart, J-C., 2004, Atherogenic Lipoprotein Particles in Atherosclerosis., Circulation, 109 [suppl III], III-2–III-7. |
[43] | Sniderman, A. D., Scantlebury, T. and Cianflone, K., 2001, Hypertriglyceridemic hyperapo B: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus., Ann Intern Med, 135 (6), 447–459. |
[44] | Dehghan, A., Van Hoek, M., Sijbrands, E. J., Hofman, A., and Witteman, J.C., 2008. High serum uric acid as a novel risk factor for type 2 diabetes., Diabetes Care, 31 (2), 361–362. |
[45] | Kramer, C. K., Von Mühlen, D., Jassal, S. K., and Barrett-Connor, E., 2009, Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose. The Rancho Bernardo Study., Diabetes Care, 32 (7), 1272–1273. |
[46] | Nakanishi, N., Okamoto, M., Yoshida, H., Matsuo, Y., Suzuki, K., and Tatara, K., 2003, Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workers,” European Journal of Epidemiology, 18 (6): 523–530. |
[47] | Kodama, S., Saito, K., Yachi, Y., Asumi, M., Sugawara, A., Totsuka, K., Saito, A., and Sone, H., 2009, Association between serum uric acid and development of type 2 diabetes., Diabetes Care, 32 (9), 1737–1742. |
[48] | Mahmud, I., Bhowmik, D., Hossain, Shahdat., Uddin, Md. Mesbah., Neaz, Sharif., Das, Arun., Masum, Nuruzzaman., Shahjalal, Hussain., and Alam, Sohrab., 2016, Interrelationship of Serum Uric Acid Levels and Cardiovascular Disease Risk Factors in Bangladeshi Patients Treated with Antihypertensive Drugs., British Journal of Medicine & Medical Research, 17(5), 1-11, Article no.BJMMR.27559. |
[49] | Juraschek, S. P., Tunstall-Pedoe, H., and Woodward, M., 2014, Serum uric acid and the risk of mortality during 23 years follow-up in the Scottish heart health extended cohort study., Atherosclerosis, 233 (2), 623–629. |
[50] | Verdecchia, P., Schillaci, G., Reboldi, G., Santeusanio, F., Porcellati, C., and Brunetti, P., 2000, Relation between serum uric acid and risk of cardiovascular disease in essential hypertension. The PIUMA study., Hypertension, 36 (6), 1072-1078. |
[51] | Freedman, D. S., Williamson, D. F., Gunter, E. W., and Byers, T., 1995, Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I epidemiologic follow-up study., Am J Epidemeol., 141 (7), 637-644. |
[52] | Desideri, G., Castaldo, G., Lombardi, A., Mussap, M., Testa, A., Pontremoli, R., Punzi, L., and Borghi, C., 2014, Is it time to revise the normal range of serum uric acid levels? Eur Rev Med Pharmacol Sci., 18 (9), 1295-1306. |